Results 11 to 20 of about 37,864 (338)
Electroconvulsive therapy and muscle relaxants [PDF]
Anesthesia and Pain Medicine, 2023 Hong Seuk Yang, Kyoung-Woon Joung
doaj +2 more sources
The Use of Muscle Relaxants and Reversal Agents in a Setting Without Cost Restrictions: Experience from a Tertiary Academic Hospital in the Netherlands [PDF]
Therapeutics and Clinical Risk Management, 2022 Chris H Martini,1 GH Maarten Honing,1 Lori D Bash,2 Erik Olofsen,1 Marieke Niesters,1 Monique van Velzen,1 Albert Dahan,1 Martijn Boon1 1Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands; 2Center for Observational ...
Martini CH +7 more
doaj +2 more sources
Effects of muscle relaxants on ischaemia damage in skeletal muscle [PDF]
Scientific Reports, 2018 Muscle ischaemia is frequently induced intraoperatively by i.e. a surgical tourniquet or during the re-grafting phase of a free muscle transplant. The resulting muscle cell damage may impact on postoperative recovery. Neuromuscular paralysis may mitigate
Thomas Ledowski +4 more
doaj +2 more sources
Muscle Relaxants Allergy [PDF]
International Journal of Immunopathology and Pharmacology, 2011 The most common agents that are responsible for intraoperative anaphylaxis are muscle relaxants. In fact, neuromuscular blocking agents (NMBAs) contribute to 50–70% of allergic reactions during anaesthesia. The main mechanism of hypersensitivity reactions to NMBAs is represented by acute type I allergic reactions and the most severe form is ...
PERONI, DIEGO +6 more
openaire +5 more sources
Estimation of the effect-site equilibration rate constant using the time-to-peak effect of muscle relaxants measured by train-of-four stimulation during general anesthesia induction [PDF]
Korean Journal of Anesthesiology, 2018 Background The concept of the effect-site concentration of anesthetic agents is important. The effect compartment model can be explained using the concepts of effect-site concentration and effect-site equilibration rate constant (ke0).
Se Yeon Park +4 more
doaj +1 more source
Anaesthetic Management of a Patient with Myasthenia Gravis for Laparascopic Cholecystectomy: A Case Report [PDF]
Journal of Clinical and Diagnostic Research, 2019 Myasthenia gravis is an autoimmune disease, which presents as fatigue and muscle weakness due to destruction of nicotinic receptors. Perioperative management of such patients is challenging due to altered pharmacology of drugs especially muscle relaxants
Jaya Choudhary +2 more
doaj +1 more source
Frontiers in Physiology, 2022 A line of studies in the 1960s–1980s suggested that muscle relaxants do not work uniformly on all skeletal muscles, though its mechanism has not been clarified.
Manami Yamashita +4 more
doaj +1 more source
Therapeutic Advances in Drug Safety, 2021 Background: Patients with diabetic kidney disease (DKD) are at an increased risk of frailty. The exposure to muscle relaxants frequently leads to adverse effects despite their modest therapeutic efficacy, but whether muscle relaxants predispose users to ...
Szu-Ying Lee +5 more
doaj +1 more source
Frontiers in Medicine, 2021 Objective: The pharmacokinetics and pharmacodynamics of ECMO-supported sedative, analgesic, and muscle relaxants have changed, but there are insufficient data to determine the optimal dosing strategies for these agents.
Fang Wu +5 more
doaj +1 more source
Cholinergic Chemotransmission and Anesthetic Drug Effects at the Carotid Bodies
Molecules, 2020 General anesthesia is obtained by administration of potent hypnotics, analgesics and muscle relaxants. Apart from their intended effects (loss of consciousness, pain relief and muscle relaxation), these agents profoundly affect the control of breathing ...
Maarten Honing +5 more
doaj +1 more source